Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity.

Saved in:
Bibliographic Details
Title: Immunoglobulin replacement products protect against SARS-CoV-2 infection in vivo despite poor neutralizing activity.
Authors: Zimmerman O; Department of Medicine, and., Altman Doss AM; Department of Pediatrics, Washington University in St. Louis, St. Louis, Missouri, USA., Ying B; Department of Medicine, and., Liang CY; Department of Pathology and Immunology., Mackin SR; Department of Pathology and Immunology., Davis-Adams HG; Department of Medicine, and., Adams LJ; Department of Pathology and Immunology., VanBlargan LA; Department of Medicine, and., Chen RE; Department of Pathology and Immunology., Scheaffer SM; Department of Medicine, and., Desai P; Department of Medicine, and., Raju S; Department of Pathology and Immunology., Mantia TL; Department of Medicine, and., O'Shaughnessy CC; Department of Medicine, and., Monroy JM; Department of Medicine, and., Wedner HJ; Department of Medicine, and., Rigell CJ; Department of Medicine, and., Kau AL; Department of Medicine, and.; Department of Molecular Microbiology.; Center for Women's Infectious Disease Research., Dy TB; Department of Medicine, and., Ren Z; Department of Medicine, and., Turner JS; Department of Pathology and Immunology., O'Halloran JA; Department of Medicine, and., Presti RM; Department of Medicine, and.; The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, and.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, Missouri, USA., Kendall PL; Department of Medicine, and., Fremont DH; Department of Pathology and Immunology., Ellebedy AH; Department of Pathology and Immunology.; Department of Molecular Microbiology.; The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, and.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, Missouri, USA., Diamond MS; Department of Medicine, and.; Department of Pathology and Immunology.; Department of Molecular Microbiology.; The Andrew M. and Jane M. Bursky Center for Human Immunology & Immunotherapy Programs, and.; Center for Vaccines and Immunity to Microbial Pathogens, Washington University School of Medicine, St. Louis, Missouri, USA.
Source: JCI insight [JCI Insight] 2024 Feb 08; Vol. 9 (3). Date of Electronic Publication: 2024 Feb 08.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 101676073 Publication Model: Electronic Cited Medium: Internet ISSN: 2379-3708 (Electronic) Linking ISSN: 23793708 NLM ISO Abbreviation: JCI Insight Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2379-3708
DOI:10.1172/jci.insight.176359